- A successful drug launch.
- A regulatory failure.
- A successful pharmacovigilance system detecting a significant safety signal.
- A minor inconvenience for patients.
148. A drug is recalled from the market due to unacceptable severe adverse effects identified through post-marketing surveillance. What medicinal epidemiological outcome does this represent?
Facebook
WhatsApp
